Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy, radiosurgery, and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Elekta also provides radiosurgery, clinical management, radiation therapy, and related equipment for the treatment of cancer and brain disorders. It also provides automation and integration systems, patient positioning and immobilization solutions, personalized imaging tools, radiotherapy treatment planning systems, and beam shaping solutions. Elekta was founded on October 10, 1972, and is headquartered in Stockholm, Stockholms Lan, Sweden.

Visualase, Inc. was founded in 2005 as a spin-off from BioTex, Inc., the original developer and current manufacturer of the Visualase technology. Visualase, Inc. is currently a privately held company located in Houston, Texas.

Hologic engages in the development, manufacture, and supply of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Products The company operates in four segments: Breast Health; Diagnostics; GYN Surgical; and Skeletal Health. BREAST HEALTH PRODUCTS The company's breast health business offers a line of breast imaging products, including the Selenia full field digital mammography system, a series of screen-film mammography systems, breast biopsy image guidance systems, computer-aided detection (CAD) systems for both screen-film and digital mammography, and DirectRay digital detectors. Its breast health business also includes its Interventional Breast Solutions family of products including breast biopsy devices, its MammoSite radiation therapy system and the MammoPad breast cushion. The company's photoconductor coating business, which it acquired in connection with its acquisition of its selenium coating capabilities for its digital detectors, is also a component of its breast health business. DirectRay Digital Detector: The company's DirectRay flat panel detector technology employs an amorphous selenium (a-Se) photoconductor to directly convert x-ray photons into an electrical signal. Selenia Full Field Digital Mammography System: The Selenia full field digital mammography system is based on its proprietary, amorphous selenium DirectRay digital detector, which preserves image quality by using amorphous selenium to directly convert x-rays to electronic signals, without first converting them to light. This direct conversion process preserves image sharpness by eliminating light diffusion.

Transmed7 LLC is a private company headquartered in Phoenix, AZ. The firm develops medical devices. It was founded in 2010 by Eugene H. Vetter and James W. Vetter. Eugene H. Vetter has been the CEO since the company founding.\nThe company says this about itself: TransMed7, LLC is a medical and technology-based organization focused on the highly efficient development of innovative, minimally-invasive medical devices aimed at providing new solutions for doctors and their patients. With particular expertise in oncologic, regenerative, and cardiovascular disease, TransMed7 and its team of clinicians, scientists, and engineers have developed a portfolio of next-generation platform devices that are expected to be market leaders in their targeted fields of medicine. TransMed7 accomplishes this through application of a wholly new approach in its business plan and structure, enabling these new transformational technologies from rapid development through commercial manufacturing or where appropriate, handoff to our Strategic Partners.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden.

Koh Young Technology, Inc. engages in the development and manufacture of inspection and measurement automation equipment. Its products include 3D SPI systems, bump inspection systems for printed circuit board wrapping, and semiconductor substrate bump. The company was founded on April 25, 2002 by Kwang-Ill, Koh and is headquartered in Seoul, South Korea.

Surgical Navigation Technology, Inc., part of Medtronic Plc, is an American company located in Broomfield, CO, that develops software and advanced surgical navigation technologies. It was founded by Mark W. Hunter. Surgical Navigation Technology, Inc. was acquired by Sofamor Danek Group, Inc. on April 30, 1996.

Dilon Technologies LLC manufactures and supplies medical imaging products. It offers Breast-Specific Gamma Imaging technique to detect breast cancer in their patients. The company was founded in 1996 and is headquartered in Newport News, VA.

Renishaw Plc engages in the design, manufacture, and marketing of metrology and healthcare products. It operates through the Metrology and Healthcare segments. The Metrology segment engages in the fields of industrial automation and motion systems. The Healthcare segment offers engineering solutions for stereotactic neurosurgery, analytical systems that identify and assess biochemical changes associated with disease formation and progression, the supply of specially configured metal additive manufacturing (AM) systems for medical and dental applications, the supply of implants to hospitals and specialist design centres for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture high-quality dental restorations. The firm serves the aerospace, agriculture, automotive, construction, healthcare and power generation industries. The company was founded by David Roberts McMurtry and Daniel John Deer on April 4, 1973 and is headquartered in Wotton-under-Edge, the United Kingdom.

Loma Linda University Medical Center (LLUMC) is the teaching hospital for Loma Linda University, which includes schools of allied health professions, behavioral health, dentistry, medicine, nursing, pharmacy, public health, and religion on the university campus in Loma Linda, California, United States. The medical center serves as a level I trauma center for San Bernardino County and the rest of the Inland Empire. The hospital has two helipads for use by an air ambulance or other helicopter medical transport.

David Kopf Instruments manufactures medical, surgical, ophthalmic, and veterinary instruments and apparatus.

Nexstim Oyj engages in the provision of medical technology products. It focuses on SmartFocus product, a navigated transcranial magnetic stimulation (nTMS) technology with sophisticated three-dimensional (3D) navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. The company was founded by Risto Ilmoniemi and Pekka Puolakka on May 15, 2000 and is headquartered in Helsinki, Finland.

Endocare, Inc. develops, manufactures, and distributes medical devices and related consumables for cryoablation.

Shanghai Gamma Star Technology Development Co., Ltd., established on 2004-05-20, operating range includes special materials,medical instruments,Computer hardware and software,network,Engage in technology development in the field of computer system integration,technology transfer,technical consulting,Technical Services,Technical Contracting,Technical Training,technology intermediary,technology investment,Computer hardware and software and related products,computer system integration,Network equipment,Sales of Medical Devices,Engaged in the import and export of goods and technology,(Three types of production:6833Radionuclide treatment equipment limited to branches). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

TomoTherapy develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy:registered: platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its Hi·Art:registered: treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD:tm: treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile:tm: relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. As of February 2011, there are more than 350 TomoTherapy systems in use in 24 countries worldwide. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.